Ajanta Pharma

India is approaching a pivotal moment in the evolution of obesity and metabolic health management. As awareness grows among…

As pharma supply chains rise in strategic importance, its leaders must sharpen their business acumen and competencies to keep pace…

The session delivered comprehensive and precise insights on complaints and product recall under revised schedule M guidelines

As per the settlement with the innovator, Ajanta can launch Topiramate on February 1, 2026 or earlier under certain circumstances

In his address to the audience, Satish Agarwal, President (Tech and Operations), Ajanta Pharma, said, “At the time of…

It will largely go towards maintenance and some new expansions for the corporate office and some key expansions in the facility,…

Ajanta Pharma has reported financial results for the period ended December 31, 2020. The company has reported total income of…

Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period

Dr Ramesh Jhawar, President of Ajanta Pharma, and a veteran with over four and half decades of experience in the life sciences…

Company posted profit after tax at Rs. 95 crores